Indivior reported 279M in Gross Profit on Sales for its fiscal semester ending in March of 2026.





Gross Profit On Sales Change Date
AstraZeneca USD 12.86B 251M Jun/2026
Cassava Sciences USD -3.96M 1.16M Sep/2025
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Glaxosmithkline GBP 5.75B 2.99B Mar/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Roche Holding CHF 22.69B 600M Jun/2026
West Pharmaceutical Services USD 296.4M 7.5M Mar/2026